Pharmacokinetics of recombinant activated factor VII in trauma patients with severe bleeding

類似資料

• Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials
  著者:: Rizoli, Sandro B, 等
  出版事項: (2006)
• Cost-effectiveness analysis of recombinant activated factor VII as adjunctive therapy for bleeding control in severely injured trauma patients in Germany
  著者:: Rossaint, R, 等
  出版事項: (2006)
• A randomised, placebo-controlled, double-blind study to investigate the efficacy and safety of rFVIIa as adjunctive therapy for control of bleeding in patients with severe blunt trauma: a re-analysis following the exclusion of early (< 48 hours) deaths
  著者:: Rossaint, R, 等
  出版事項: (2005)
• Safety of rFVIIa in hemodynamically unstable polytrauma patients with traumatic brain injury: post hoc analysis of 30 patients from a prospective, randomized, placebo-controlled, double-blind clinical trial
  著者:: Kluger, Yoram, 等
  出版事項: (2007)
• Recommendations on the use of recombinant activated factor VII as an adjunctive treatment for massive bleeding – a European perspective
  著者:: Vincent, Jean-Louis, 等
  出版事項: (2006)